Pluri (PLUR) EBIT (2010 - 2025)
Pluri's (PLUR) quarterly EBIT came in at -$6.5 million in Q4 2025, down 31.25% year-over-year from -$9.5 million in Q4 2024, and down 2.46% quarter-over-quarter from -$6.4 million in Q3 2025.
Analysis
Pluri (PLUR) EBIT (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported EBIT for 16 consecutive years, with -$6.5 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, EBIT fell 31.25% year-over-year to -$6.5 million in Q4 2025; TTM through Dec 2025 was -$24.9 million, a 14.52% decrease from a year earlier, with the FY2025 full-year figure at -$22.2 million, changed 0.08% from the prior year.
- EBIT was -$6.5 million for Q4 2025 at Pluri, down from -$6.4 million in the prior quarter.
- Over five years, EBIT peaked at -$5.0 million in Q4 2024 and troughed at -$14.6 million in Q2 2021.
- A 5-year average of -$7.7 million and a median of -$6.6 million in 2023 frame the typical range for EBIT.
- Across the five-year window, EBIT sank 92.26% in 2021 and surged 39.49% in 2022, its largest moves.
- Over 5 years, EBIT stood at -$10.8 million in 2021, then soared by 38.13% to -$6.7 million in 2022, then rose by 21.95% to -$5.2 million in 2023, then gained by 4.91% to -$5.0 million in 2024, then tumbled by 31.25% to -$6.5 million in 2025.
- The last three EBIT figures came in at -$6.5 million (Q4 2025), -$6.4 million (Q3 2025), and -$6.6 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 58.42 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -117.27 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -51.91 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 57.70 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -52.20 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -126.55 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 22.64 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 13.29 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 434,000.00 |
| 10 | Pluri | 11.95 Mn | -536,034.04 | 86,000.00 | -6.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -6.51 Mn |
| Sep 30, 2025 | -6.35 Mn |
| Jun 30, 2025 | -6.62 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Dec 31, 2024 | -4.96 Mn |
| Sep 30, 2024 | -5.20 Mn |
| Jun 30, 2024 | -6.03 Mn |
| Mar 31, 2024 | -5.53 Mn |
| Dec 31, 2023 | -5.21 Mn |
| Sep 30, 2023 | -5.38 Mn |
| Jun 30, 2023 | -6.54 Mn |
| Mar 31, 2023 | -7.10 Mn |
| Dec 31, 2022 | -6.68 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Jun 30, 2022 | -8.88 Mn |
| Mar 31, 2022 | -10.48 Mn |
| Dec 31, 2021 | -10.80 Mn |
| Sep 30, 2021 | -11.44 Mn |
| Jun 30, 2021 | -14.59 Mn |
| Mar 31, 2021 | -14.23 Mn |